$VRTX
Vertex Pharmaceuticals Inc

2013 Q2 Form 10-Q Financial Statement

#000087532013000038 Filed on August 02, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2 2012 Q1
Revenue $310.8M $418.3M $438.7M
YoY Change -25.71% 265.57% 495.61%
Cost Of Revenue $24.70M $104.5M $25.92M
YoY Change -76.38% 1834.66%
Gross Profit $286.1M $313.8M $412.8M
YoY Change -8.83% 187.8% 460.42%
Gross Profit Margin 92.05% 75.01% 94.09%
Selling, General & Admin $105.1M $117.5M $111.1M
YoY Change -10.58% 21.57% 55.4%
% of Gross Profit 36.73% 37.45% 26.92%
Research & Development $214.0M $196.5M $196.4M
YoY Change 8.88% 13.21% 23.81%
% of Gross Profit 74.81% 62.64% 47.57%
Depreciation & Amortization $10.50M $8.600M $8.560M
YoY Change 22.09% -1.15% -3.82%
% of Gross Profit 3.67% 2.74% 2.07%
Operating Expenses $319.1M $314.1M $307.5M
YoY Change 1.6% 16.2% 33.62%
Operating Profit -$47.03M -$10.77M $91.65M
YoY Change 336.69% -93.51% -157.32%
Interest Expense -$6.727M -$179.0K -$150.0K
YoY Change 3658.1% -102.57% -101.25%
% of Operating Profit -0.16%
Other Income/Expense, Net -$34.00K -$3.635M -$3.741M
YoY Change -99.06%
Pretax Income -$53.79M -$14.41M $87.91M
YoY Change 273.43% -91.76% -149.92%
Income Tax $558.0K $20.06M $32.00K
% Of Pretax Income 0.04%
Net Earnings -$57.17M -$64.93M $91.59M
YoY Change -11.96% -62.7% -152.01%
Net Earnings / Revenue -18.4% -15.52% 20.88%
Basic Earnings Per Share -$0.26 -$0.31 $0.44
Diluted Earnings Per Share -$0.26 -$0.31 $0.43
COMMON SHARES
Basic Shares Outstanding 222.1M shares 211.3M shares 208.0M shares
Diluted Shares Outstanding 222.1M shares 211.3M shares 219.3M shares

Balance Sheet

Concept 2013 Q2 2012 Q2 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.431B $1.223B $981.0M
YoY Change 17.01% 106.24% 19.2%
Cash & Equivalents $531.2M $454.1M $454.1M
Short-Term Investments $899.0M $769.0M $713.0M
Other Short-Term Assets $101.0M $97.00M $93.00M
YoY Change 4.12% 14.12% 257.69%
Inventory $19.51M $88.00M $130.0M
Prepaid Expenses
Receivables $164.9M $186.0M $232.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.717B $1.593B $1.436B
YoY Change 7.74% 92.63% 64.49%
LONG-TERM ASSETS
Property, Plant & Equipment $581.7M $272.6M $170.3M
YoY Change 113.43% 223.7% 139.9%
Goodwill $31.00M $30.99M $30.99M
YoY Change 0.03% -7.49%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.287M $10.41M $10.82M
YoY Change -58.81% -29.95% -78.37%
Total Long-Term Assets $867.7M $1.012B $910.0M
YoY Change -14.23% 8.09% 36.84%
TOTAL ASSETS
Total Short-Term Assets $1.717B $1.593B $1.436B
Total Long-Term Assets $867.7M $1.012B $910.0M
Total Assets $2.584B $2.605B $2.346B
YoY Change -0.79% 47.75% 52.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.57M $59.35M $73.23M
YoY Change -18.17% -11.78% 109.22%
Accrued Expenses $260.8M $271.5M $241.5M
YoY Change -3.91% 92.3% 88.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $11.00M
YoY Change
Total Short-Term Liabilities $381.7M $379.7M $357.0M
YoY Change 0.51% -20.72% -14.18%
LONG-TERM LIABILITIES
Long-Term Debt $387.0M $400.0M $400.0M
YoY Change -3.25% 0.0% 0.0%
Other Long-Term Liabilities $16.05M $28.01M $10.89M
YoY Change -42.7% 349.38% -93.6%
Total Long-Term Liabilities $16.05M $28.01M $10.89M
YoY Change -42.7% 349.38% -98.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $381.7M $379.7M $357.0M
Total Long-Term Liabilities $16.05M $28.01M $10.89M
Total Liabilities $1.036B $407.7M $1.415B
YoY Change 154.01% -68.97% 23.37%
SHAREHOLDERS EQUITY
Retained Earnings -$3.887B
YoY Change
Common Stock $5.211B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.322B $1.038B $930.0M
YoY Change
Total Liabilities & Shareholders Equity $2.584B $2.605B $2.346B
YoY Change -0.79% 47.75% 52.54%

Cashflow Statement

Concept 2013 Q2 2012 Q2 2012 Q1
OPERATING ACTIVITIES
Net Income -$57.17M -$64.93M $91.59M
YoY Change -11.96% -62.7% -152.01%
Depreciation, Depletion And Amortization $10.50M $8.600M $8.560M
YoY Change 22.09% -1.15% -3.82%
Cash From Operating Activities -$900.0K $118.4M $2.916M
YoY Change -100.76% -154.76% -101.56%
INVESTING ACTIVITIES
Capital Expenditures -$1.800M -$15.50M $6.155M
YoY Change -88.39% 49.04% -225.61%
Acquisitions
YoY Change
Other Investing Activities -$2.900M -$54.50M $216.0K
YoY Change -94.68% -129.75% -99.95%
Cash From Investing Activities -$4.700M -$70.00M -$231.7M
YoY Change -93.29% -140.53% -157.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 157.5M 137.7M 21.50M
YoY Change 14.38% 149.91% -231.1%
NET CHANGE
Cash From Operating Activities -900.0K 118.4M $2.916M
Cash From Investing Activities -4.700M -70.00M -231.7M
Cash From Financing Activities 157.5M 137.7M 21.50M
Net Change In Cash 151.9M 186.1M $2.916M
YoY Change -18.38% 1504.31% -98.56%
FREE CASH FLOW
Cash From Operating Activities -$900.0K $118.4M $2.916M
Capital Expenditures -$1.800M -$15.50M $6.155M
Free Cash Flow $900.0K $133.9M -$3.239M
YoY Change -99.33% -165.06% -98.22%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
101292000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
48570000 USD
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164866000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
143250000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
264884000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
260849000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-550000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1230000 USD
CY2013Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
5208431000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4519448000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1214000 USD
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
0 USD
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
6700000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73306000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59616000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
4230000 USD
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
285300000 USD
CY2012Q4 us-gaap Assets
Assets
2759288000 USD
CY2013Q2 us-gaap Assets
Assets
2584329000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1589585000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
1716590000 USD
CY2013Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
899449000 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
831808000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
13707000 USD
CY2013Q2 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
10664000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
21576000 USD
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
29072000 USD
CY2013Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
28088000 USD
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
15170000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
43829000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
3468000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5048000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
5048000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
11585000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
14053000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
4627000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
-5077000 USD
CY2013Q2 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
38752000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
531247000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
489407000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
454061000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
475320000 USD
CY2013Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
56500000 USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
217286868 shares
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
217286868 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
2149000 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
2300000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-365861000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
27039000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-64976000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57246000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
30463000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-9158000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
26749000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-4547000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
53788000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-375019000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34513000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-61793000 USD
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
290700000 USD
CY2013Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
421300000 USD
CY2012Q4 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
400000000 USD
CY2013Q2 us-gaap Convertible Subordinated Debt Noncurrent
ConvertibleSubordinatedDebtNoncurrent
0 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
24695000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
130467000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
55650000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
104549000 USD
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
367683000 USD
us-gaap Costs And Expenses
CostsAndExpenses
776163000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1134339000 USD
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
429075000 USD
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1100000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
399842000 USD
CY2013Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.04
CY2013Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.07
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
127600000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
27566000 USD
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
32900000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
96242000 USD
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
84066000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2600000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-521000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1500000000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
681000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
60300000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
149706000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
280367000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17225000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21245000 USD
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
25024000 USD
us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
23167000 USD
CY2013Q2 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
13236000 USD
CY2012Q2 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
9874000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.67
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.67
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-52000 USD
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
549000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
382000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
299000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1214000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
-1214000 USD
us-gaap Extraordinary Item Earnings Per Share Impact Net
ExtraordinaryItemEarningsPerShareImpactNet
1.30
CY2013Q2 us-gaap Goodwill
Goodwill
30992000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
30992000 USD
CY2013Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2012Q2 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
412900000 USD
CY2012Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2013Q2 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-63511000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-506451000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
73503000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14405000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-132112000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20063000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20095000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1799000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15313000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
53374000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2483000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18462000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
9310000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
11316000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6842000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-25764000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-34288000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6620000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-130661000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
19310000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
485000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-414000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
40053000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
18152000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-31812000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
4146000 USD
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-11695000 USD
us-gaap Interest Paid
InterestPaid
6700000 USD
us-gaap Interest Paid
InterestPaid
6700000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
11751000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
15393000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
30464000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
19509000 USD
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3103000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
3754000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4655000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
11317000 USD
us-gaap Inventory Write Down
InventoryWriteDown
5083000 USD
us-gaap Inventory Write Down
InventoryWriteDown
78000000 USD
CY2012Q2 us-gaap Inventory Write Down
InventoryWriteDown
78000000 USD
CY2013Q2 us-gaap Inventory Write Down
InventoryWriteDown
5100000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
1035666000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1524906000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2759288000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2584329000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
381652000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
432624000 USD
CY2013Q2 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
31900000 USD
CY2013Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2012Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 USD
CY2012Q4 us-gaap Minority Interest
MinorityInterest
196672000 USD
CY2013Q2 us-gaap Minority Interest
MinorityInterest
186996000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
684000 USD
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
878000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
41840000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
-21259000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
151353000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
159217000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-42287000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-301745000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66705000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
121321000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-57165000 USD
us-gaap Net Income Loss
NetIncomeLoss
-365181000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-64931000 USD
us-gaap Net Income Loss
NetIncomeLoss
26659000 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4547000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9158000 USD
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
30463000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
26749000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-57165000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-64931000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-365181000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
26399000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-64931000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
26403000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-57165000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
89000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-521000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
130222000 USD
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
104341000 USD
CY2013Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
us-gaap Operating Income Loss
OperatingIncomeLoss
80879000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-56933000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-495221000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-365181000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10770000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4287000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9668000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-150000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
125000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
380000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-45000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-680000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-81000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
255000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
105000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-170000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-159000 USD
CY2013Q2 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
250600000 USD
CY2012Q4 us-gaap Other Indefinite Lived Intangible Assets
OtherIndefiniteLivedIntangibleAssets
663500000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20417000 USD
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
23622000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13902000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16049000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
5469000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
5857000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-755000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-130000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11230000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7376000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6578000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3635000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
898706000 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
777604000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21698000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18408000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
24673000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43231000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
158003000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
207872000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-44115000 USD
us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
31800000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
502188000 USD
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
830906000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
-34468000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
-61712000 USD
us-gaap Profit Loss
ProfitLoss
53408000 USD
us-gaap Profit Loss
ProfitLoss
-374339000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
581738000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
433609000 USD
CY2013Q2 us-gaap Redeemable Noncontrolling Interest Equity Preferred Fair Value
RedeemableNoncontrollingInterestEquityPreferredFairValue
39214000 USD
CY2012Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Fair Value
RedeemableNoncontrollingInterestEquityPreferredFairValue
38530000 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
158000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
12246000 USD
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
0 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
196544000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
392915000 USD
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
222455000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
440550000 USD
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
58288000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
69983000 USD
CY2013Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
122000 USD
CY2012Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
31934000 USD
CY2012Q2 us-gaap Restructuring Charges
RestructuringCharges
594000 USD
us-gaap Restructuring Charges
RestructuringCharges
815000 USD
us-gaap Restructuring Charges
RestructuringCharges
954000 USD
CY2013Q2 us-gaap Restructuring Charges
RestructuringCharges
776000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
22459000 USD
CY2012Q1 us-gaap Restructuring Reserve
RestructuringReserve
24830000 USD
CY2011Q4 us-gaap Restructuring Reserve
RestructuringReserve
25473000 USD
CY2013Q2 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
5047000 USD
CY2012Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
4758000 USD
CY2013Q2 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
17005000 USD
CY2012Q4 us-gaap Restructuring Reserve Noncurrent
RestructuringReserveNoncurrent
18570000 USD
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-1276000 USD
us-gaap Restructuring Reserve Period Increase Decrease
RestructuringReservePeriodIncreaseDecrease
-1483000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
7411000 USD
CY2012Q2 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
3725000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
7422000 USD
CY2013Q2 us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
3849000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3887048000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3521867000 USD
CY2012Q2 us-gaap Revenues
Revenues
418305000 USD
us-gaap Revenues
Revenues
857042000 USD
CY2013Q2 us-gaap Revenues
Revenues
310750000 USD
us-gaap Revenues
Revenues
639118000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
92693000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
72461000 USD
CY2012Q2 us-gaap Royalty Revenue
RoyaltyRevenue
33480000 USD
CY2013Q2 us-gaap Royalty Revenue
RoyaltyRevenue
49120000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
748648000 USD
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
254789000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
373273000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
522170000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
228660000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
117514000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
199400000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106521000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
72625000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
59067000 USD
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
41350000 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
31379000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
402265000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
213729000 USD
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
163477000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
999180000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
1322453000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1195852000 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1509449000 USD
CY2012Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1205693000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
928476000 USD
CY2012Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
98000000 USD
us-gaap Undistributed Earnings
UndistributedEarnings
0 USD
us-gaap Undistributed Earnings
UndistributedEarnings
-260000 USD
CY2013Q2 us-gaap Undistributed Earnings
UndistributedEarnings
0 USD
CY2012Q2 us-gaap Undistributed Earnings
UndistributedEarnings
0 USD
CY2012Q2 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
0 USD
us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
-256000 USD
CY2013Q2 us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
0 USD
us-gaap Undistributed Earnings Diluted
UndistributedEarningsDiluted
0 USD
CY2013Q2 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates and Summary of Significant Accounting Policies</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these condensed consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, restructuring expense, the fair value of intangible assets, noncontrolling interest (Alios) and the income tax provision. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections, that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div><div style="line-height:120%;padding-bottom:12px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company's significant accounting policies are described in Note&#160;A, "Nature of Business and Accounting Policies," in the 2012 Annual Report on Form&#160;10-K.</font></div></div>
us-gaap Valuation Allowances And Reserves Adjustments
ValuationAllowancesAndReservesAdjustments
11839000 USD
CY2013Q2 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
80582000 USD
CY2012Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
75393000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218795000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211344000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212957000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
222053000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
222053000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
209681000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218795000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211344000 shares
vrtx Amounts Reclassified From Accumulated Other Comprehensive Income Loss
AmountsReclassifiedFromAccumulatedOtherComprehensiveIncomeLoss
0 USD
CY2012Q4 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1321215000 USD
CY2013Q2 vrtx Cash Cash Equivalents And Available For Sale Securities Fair Value
CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue
1430696000 USD
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1321019000 USD
CY2013Q2 vrtx Cash Cash Equivalents Available For Sale Securities Amortized Cost
CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost
1430659000 USD
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableForSaleSecuritiesGrossUnrealizedGain
217000 USD
CY2013Q2 vrtx Cash Cash Equivalents Available For Sale Securities Gross Unrealized Gain
CashCashEquivalentsAvailableForSaleSecuritiesGrossUnrealizedGain
193000 USD
CY2012Q4 vrtx Cash Cash Equivalents Available For Sale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableForSaleSecuritiesUnrealizedLossGross
21000 USD
CY2013Q2 vrtx Cash Cash Equivalents Available For Sale Securities Unrealized Loss Gross
CashCashEquivalentsAvailableForSaleSecuritiesUnrealizedLossGross
156000 USD
vrtx Collaborative Revenues
CollaborativeRevenues
35933000 USD
CY2013Q2 vrtx Collaborative Revenues
CollaborativeRevenues
6841000 USD
vrtx Collaborative Revenues
CollaborativeRevenues
24255000 USD
CY2012Q2 vrtx Collaborative Revenues
CollaborativeRevenues
11552000 USD
CY2012Q4 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
268031000 USD
CY2013Q2 vrtx Construction Financing Obligation Noncurrent
ConstructionFinancingObligationNoncurrent
359100000 USD
CY2013Q2 vrtx Deferred Revenue Royalty Purchase Agreement
DeferredRevenueRoyaltyPurchaseAgreement
75200000 USD
vrtx Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
3188000 shares
vrtx Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
0 shares
CY2013Q2 vrtx Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
0 shares
CY2012Q2 vrtx Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
0 shares
vrtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndEmployeeStockPurchasePlan
88000 shares
CY2012Q2 vrtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndEmployeeStockPurchasePlan
0 shares
CY2013Q2 vrtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndEmployeeStockPurchasePlan
0 shares
vrtx Incremental Common Shares Attributable To Unvested Restricted Stock Units And Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToUnvestedRestrictedStockUnitsAndEmployeeStockPurchasePlan
0 shares
CY2011Q2 vrtx Initial Term Of Lease Agreement
InitialTermOfLeaseAgreement
P15Y
CY2011Q2 vrtx Lease Agreement Number Of Leases
LeaseAgreementNumberOfLeases
2 leases
CY2011Q2 vrtx Lease Agreements Number Of Buildings
LeaseAgreementsNumberOfBuildings
2 building
CY2010Q1 vrtx Lease Term
LeaseTerm
P15Y
CY2011Q2 vrtx Optional Term Of Lease Agreement
OptionalTermOfLeaseAgreement
P10Y
vrtx Other Comprehensive Income Loss Before Reclassifications
OtherComprehensiveIncomeLossBeforeReclassifications
-680000 USD
CY2008 vrtx Proceeds From Sale Of Royalty Rights
ProceedsFromSaleOfRoyaltyRights
160000000 USD
CY2012Q2 vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
2488000 USD
CY2013Q2 vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
2666000 USD
vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
4974000 USD
vrtx Restructuring Reserve Settled With Cash Receipt From Sublease
RestructuringReserveSettledWithCashReceiptFromSublease
5331000 USD
CY2011Q2 vrtx Square Footage Of Leased Property
SquareFootageOfLeasedProperty
1100000 squarefeet
vrtx Valuation Allowances And Reserves Provision
ValuationAllowancesAndReservesProvision
-127843000 USD
vrtx Valuation Allowances And Reserves Sales Credits Or Payments Current
ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent
-134493000 USD
CY2013Q2 dei Amendment Flag
AmendmentFlag
false
CY2013Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2013Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q2 dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
CY2013Q2 dei Document Type
DocumentType
10-Q
CY2013Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000875320
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
232812301 shares
CY2013Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2013Q2 dei Entity Registrant Name
EntityRegistrantName
VERTEX PHARMACEUTICALS INC / MA

Files In Submission

Name View Source Status
0000875320-13-000038-index-headers.html Edgar Link pending
0000875320-13-000038-index.html Edgar Link pending
0000875320-13-000038.txt Edgar Link pending
0000875320-13-000038-xbrl.zip Edgar Link pending
a2013q210-q.htm Edgar Link pending
a2013q210-q_exhibit102.htm Edgar Link pending
a2013q210-q_exhibit103.htm Edgar Link pending
a2013q210-q_exhibit104.htm Edgar Link pending
a2013q210-q_exhibit105.htm Edgar Link pending
a2013q210-q_exhibit106.htm Edgar Link pending
a2013q210-q_exhibit107.htm Edgar Link pending
a2013q210-q_exhibit311.htm Edgar Link pending
a2013q210-q_exhibit312.htm Edgar Link pending
a2013q210-q_exhibit321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
vrtx-20130630.xml Edgar Link completed
vrtx-20130630.xsd Edgar Link pending
vrtx-20130630_cal.xml Edgar Link unprocessable
vrtx-20130630_def.xml Edgar Link unprocessable
vrtx-20130630_lab.xml Edgar Link unprocessable
vrtx-20130630_pre.xml Edgar Link unprocessable